273 related articles for article (PubMed ID: 28796032)
21. Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion.
Ye JZ; Chen JZ; Li ZH; Bai T; Chen J; Zhu SL; Li LQ; Wu FX
World J Gastroenterol; 2017 Nov; 23(41):7415-7424. PubMed ID: 29151695
[TBL] [Abstract][Full Text] [Related]
22. Development of a computed tomography-based radiomics nomogram for prediction of transarterial chemoembolization refractoriness in hepatocellular carcinoma.
Niu XK; He XF
World J Gastroenterol; 2021 Jan; 27(2):189-207. PubMed ID: 33510559
[TBL] [Abstract][Full Text] [Related]
23. Nomogram for prediction of the international study Group of Liver Surgery (ISGLS) grade B/C Posthepatectomy liver failure in HBV-related hepatocellular carcinoma patients: an external validation and prospective application study.
Ye JZ; Mai RY; Guo WX; Wang YY; Ma L; Xiang BD; Cheng SQ; Li LQ
BMC Cancer; 2020 Oct; 20(1):1036. PubMed ID: 33115425
[TBL] [Abstract][Full Text] [Related]
24. Development and Validation of a Prediction Model for Hepatitis B Virus-Related Hepatocellular Carcinoma Patients Receiving Postoperative Adjuvant Transarterial Chemoembolization.
Tu X; Zhang J; Li M; Lu F; Wang T; Gong W; Xiang B
J Hepatocell Carcinoma; 2023; 10():1881-1895. PubMed ID: 37901717
[TBL] [Abstract][Full Text] [Related]
25. Development and validation of a novel online calculator for estimating survival benefit of adjuvant transcatheter arterial chemoembolization in patients undergoing surgery for hepatocellular carcinoma.
Liang L; Li C; Wang MD; Wang H; Zhou YH; Zeng YY; Zhang WG; Chen TH; Wang NY; Li J; Zhang YM; Wang Y; Gu WM; Xing H; Diao YK; Lau WY; Zhang CW; Pawlik TM; Shen F; Huang DS; Yang T
J Hematol Oncol; 2021 Oct; 14(1):165. PubMed ID: 34641921
[TBL] [Abstract][Full Text] [Related]
26. A New Prognostic Algorithm Predicting HCC Recurrence in Patients With Barcelona Clinic Liver Cancer Stage B Who Received PA-TACE.
Hu S; Gan W; Qiao L; Ye C; Wu D; Liao B; Yang X; Jiang X
Front Oncol; 2021; 11():742630. PubMed ID: 34745962
[TBL] [Abstract][Full Text] [Related]
27. Body Composition Changes in Hepatocellular Carcinoma: Prediction of Survival to Transcatheter Arterial Chemoembolization in Combination With Clinical Prognostic Factors.
Zheng X; Cao F; Qian L; Dong J
Cancer Control; 2021; 28():10732748211038445. PubMed ID: 34569304
[TBL] [Abstract][Full Text] [Related]
28. Development and Validation of a Model Including Distinct Vascular Patterns to Estimate Survival in Hepatocellular Carcinoma.
Lin WP; Xing KL; Fu JC; Ling YH; Li SH; Yu WS; Zhang YF; Zhong C; Wang JH; Chen ZY; Lu LH; Wei W; Guo RP
JAMA Netw Open; 2021 Sep; 4(9):e2125055. PubMed ID: 34515782
[TBL] [Abstract][Full Text] [Related]
29. A new prognostic model predicting hepatocellular carcinoma early recurrence in patients with microvascular invasion who received postoperative adjuvant transcatheter arterial chemoembolization.
Mao S; Shan Y; Yu X; Huang J; Fang J; Wang M; Fan R; Wu S; Lu C
Eur J Surg Oncol; 2023 Jan; 49(1):129-136. PubMed ID: 36031472
[TBL] [Abstract][Full Text] [Related]
30. Inflammation scores predict survival for hepatitis B virus-related hepatocellular carcinoma patients after transarterial chemoembolization.
Zhou DS; Xu L; Luo YL; He FY; Huang JT; Zhang YJ; Chen MS
World J Gastroenterol; 2015 May; 21(18):5582-90. PubMed ID: 25987783
[TBL] [Abstract][Full Text] [Related]
31. Prognostic Nomograms Stratify Survival of Patients with Hepatocellular Carcinoma Without Portal Vein Tumor Thrombosis After Curative Resection.
Fu YP; Yi Y; Huang JL; Jing CY; Sun J; Ni XC; Lu ZF; Cao Y; Zhou J; Fan J; Qiu SJ
Oncologist; 2017 May; 22(5):561-569. PubMed ID: 28438885
[TBL] [Abstract][Full Text] [Related]
32. Controlling nutritional status (CONUT) score-based nomogram to predict overall survival of patients with HBV-associated hepatocellular carcinoma after curative hepatectomy.
Lin ZX; Ruan DY; Jia CC; Wang TT; Cheng JT; Huang HQ; Wu XY
Clin Transl Oncol; 2020 Mar; 22(3):370-380. PubMed ID: 31201606
[TBL] [Abstract][Full Text] [Related]
33. Nomogram for individualised prediction of liver failure risk after hepatectomy in patients with resectable hepatocellular carcinoma: the evidence from ultrasound data.
Hu H; Han H; Han XK; Wang WP; Ding H
Eur Radiol; 2018 Feb; 28(2):877-885. PubMed ID: 28779402
[TBL] [Abstract][Full Text] [Related]
34. Preoperative Nomogram Incorporating Clinical Factors, Serological Markers and LI-RADS MRI Features to Predict Early Recurrence of Hepatocellular Carcinoma Treated with Transarterial Chemoembolization.
Sheng Y; Wang Q; Liu HF; Chen WH; He ZM; Wang Q
Acad Radiol; 2023 Jul; 30(7):1288-1297. PubMed ID: 36424310
[TBL] [Abstract][Full Text] [Related]
35. A novel nomogram to predict the local tumor progression after microwave ablation in patients with early-stage hepatocellular carcinoma: A tool in prediction of successful ablation.
An C; Wu S; Huang Z; Ni J; Zuo M; Gu Y; Zhang T; Huang J
Cancer Med; 2020 Jan; 9(1):104-115. PubMed ID: 31714685
[TBL] [Abstract][Full Text] [Related]
36. A nomogram predicting the recurrence of hepatocellular carcinoma in patients after laparoscopic hepatectomy.
Pan YX; Chen JC; Fang AP; Wang XH; Chen JB; Wang JC; He W; Fu YZ; Xu L; Chen MS; Zhang YJ; Li QJ; Zhou ZG
Cancer Commun (Lond); 2019 Oct; 39(1):55. PubMed ID: 31601270
[TBL] [Abstract][Full Text] [Related]
37. Prognostic nomograms for prediction of recurrence and survival after curative liver resection for hepatocellular carcinoma.
Shim JH; Jun MJ; Han S; Lee YJ; Lee SG; Kim KM; Lim YS; Lee HC
Ann Surg; 2015 May; 261(5):939-46. PubMed ID: 24950276
[TBL] [Abstract][Full Text] [Related]
38. Simplified nomograms based on platelet-associated models for survival prediction in Asian hepatocellular carcinoma patients after surgery.
Gu J; Zhang X; Wang Z; Cui R; Zhang J; Jia Y; Miao R; Fan H; Wang H; Li Y; Zhang J; Liu C; Qu K
Surg Oncol; 2019 Sep; 30():131-138. PubMed ID: 31500777
[TBL] [Abstract][Full Text] [Related]
39. Rationality and effectiveness of transarterial chemoembolization as an initial treatment for BCLC B stage HBV-related hepatocellular carcinoma.
Heng-jun G; Yao-jun Z; Min-shan C; Mei-xian C; Jun-ting H; Li X; Lau WY
Liver Int; 2014 Apr; 34(4):612-20. PubMed ID: 24028297
[TBL] [Abstract][Full Text] [Related]
40. Adjuvant Transarterial Chemoembolization Following Liver Resection for Intrahepatic Cholangiocarcinoma Based on Survival Risk Stratification.
Li J; Wang Q; Lei Z; Wu D; Si A; Wang K; Wan X; Wang Y; Yan Z; Xia Y; Lau WY; Wu M; Shen F
Oncologist; 2015 Jun; 20(6):640-7. PubMed ID: 25956404
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
